PubRank

André L Carvalho

Author PubWeight™ 21.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res 2005 1.47
2 High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients. Clin Cancer Res 2007 1.30
3 Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev 2008 1.30
4 MT1G hypermethylation is associated with higher tumor stage in prostate cancer. Cancer Epidemiol Biomarkers Prev 2005 1.18
5 Routine drainage after thyroid surgery--a meta-analysis. J Surg Oncol 2007 1.13
6 An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 2011 1.13
7 Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis. Mol Cancer Res 2006 1.09
8 Program for prostate cancer screening using a mobile unit: results from Brazil. Urology 2010 1.02
9 Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions. Breast Cancer Res Treat 2007 0.99
10 ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis. Cancer Res 2009 0.98
11 Comparison of clinical and pathologic findings of prostate cancers detected through screening versus conventional referral in Brazil. Clin Genitourin Cancer 2011 0.93
12 Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions. DNA Cell Biol 2005 0.93
13 Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck 2008 0.89
14 TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma. Int J Cancer 2009 0.87
15 Feasibility of supraomohyoid neck dissection in N1 and N2a oral cancer patients. Head Neck 2002 0.86
16 Bcl-2 targeted-therapy for the treatment of head and neck squamous cell carcinoma. Recent Pat Anticancer Drug Discov 2011 0.84
17 Oral squamous cell carcinoma: status of tight junction claudins in the different histopathological patterns and relationship with clinical parameters. A tissue-microarray-based study of 136 cases. J Clin Pathol 2010 0.81
18 Association between literacy, compliance with prostate cancer screening, and cancer aggressiveness: results from a Brazilian screening study. Int Braz J Urol 2013 0.81
19 Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical-recurrence. Int J Cancer 2008 0.79
20 Functional microarray analysis suggests repressed cell-cell signaling and cell survival-related modules inhibit progression of head and neck squamous cell carcinoma. BMC Med Genomics 2011 0.78
21 Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma. Onco Targets Ther 2013 0.77
22 The 434(G>C) polymorphism in the eosinophil cationic protein gene and its association with tissue eosinophilia in oral squamous cell carcinomas. J Oral Pathol Med 2009 0.75
23 Assessment of control selection bias in a hospital-based case-control study of upper aero-digestive tract cancers. J Cancer Epidemiol Prev 2002 0.75